Fennec PharmaceuticalsvsMerck & Company

FENC and MRK stock compared: price, dividend, valuation and results, from SEC filings.

FENC

Fennec Pharmaceuticals Inc.

$13.58

Value $468M

+6.43%
FENC's page

MRK

Merck & Company, Inc.

$143.37

Value $354B

-0.75%
MRK's page

Fennec Pharmaceuticals (FENC) has a market value of $468M and Merck & Company (MRK) $354B. Over the last year, with dividends, FENC moved +72.8% and MRK +58.8%. The P/E is 333.3 for FENC and 144.5 for MRK. Dividend yield: FENC none, MRK 2.37%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FENC$468M

    MRK$354B

    MRK is 757 times FENC

  • Revenue, 12 months

    FENC$66M

    MRK$67.4B

    MRK is 1,015 times FENC

  • Net income, 12 months

    FENC$2.0M

    MRK$2.5B

    MRK is 1,210 times FENC

  • Operating margin

    FENC5.6%

    MRK–

  • ROIC

    FENC–

    MRK3.9%

  • P/E

    FENC333.3

    MRK144.5

    FENC is 2.3 times MRK

  • Dividend yield

    FENC0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    FENC+39.9%

    MRK+98.6%

    58.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FENC+39.9%

MRK+98.6%

5010015020020222023202420252026
Returns by period
PeriodFENCWith dividendsMRKWith dividends
1 year since November 14, 2025+72.8%Price +72.8%+58.8%Price +54.3%
3 years since November 17, 2023+63.2%+17.7% a yearPrice +63.2%+54.4%+15.6% a yearPrice +40.9%
5 years since November 16, 2021+39.9%+6.9% a yearPrice +39.9%+98.6%+14.7% a yearPrice +70.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FENCFennec PharmaceuticalsMRKMerck & Company

Valuation

FENCMRK
Valuation
Price$13.58$143.37
Market value$468M$354B
Enterprise value (EV)–$399B
P/E333.3144.5
P/E, 5-year median–14.8
P/B9.57.9
EV/EBIT–83.7
Free cash flow yield0.7%4.2%

Results and growth

FENCMRK
Results and growth
Revenue, 12 months$66M$67.4B
Net income, 12 months$2.0M$2.5B
Free cash flow, 12 months$3.1M$14.7B
Earnings per share, 12 months$0.04$0.98
Revenue growth, year on year-6.1%1.3%
Revenue growth a year, past+204.7%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

FENCMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin5.6%–
Net margin3.1%3.6%
ROIC–3.9%
ROE6.3%5.2%

Balance sheet

FENCMRK
Balance sheet
Cash$49M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover11.7×2.4×

Dividends and buybacks

FENCMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FENC or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Fennec Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($354B) is about 757.1 times Fennec Pharmaceuticals ($468M), at today's prices.

How did FENC and MRK stock do over the last 5 years?

Since November 16, 2021, FENC's price moved +39.9% and MRK's +70.5%. With dividends: FENC +39.9% (+6.9% a year), MRK +98.6% (+14.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, FENC or MRK?

The dividend yield at today's price is none for Fennec Pharmaceuticals and 2.37% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of FENC and MRK?

At today's price, the P/E is 333.3 for FENC and 144.5 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Fennec Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 3.1% for Fennec Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 5.6% and –. Revenue was $66M and $67.4B.

Which is the better investment, Fennec Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.